Lidocaine attenuates the development of diabetic-induced tactile allodynia by inhibiting microglial activation (Q48245291)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 July 2011
edit
Language Label Description Also known as
English
Lidocaine attenuates the development of diabetic-induced tactile allodynia by inhibiting microglial activation
scientific article published on 25 July 2011

    Statements

    Lidocaine attenuates the development of diabetic-induced tactile allodynia by inhibiting microglial activation (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit